Twin Reno girls treated for rare disease
April 16, 2009(AP) -- Twin 5-year-old girls living with a rare disease are among the first in the country being treated for their condition at a Reno hospital after the U.S. Food and Drug Administration granted special permission to use an experimental drug.
Addi and Cassi Hempel of Reno were admitted to Renown Regional Medical Center on Monday to get the experimental treatment for Niemann-Pick Type C disease.
The FDA recently cleared them for intravenous infusions of the drug cyclodextrin, a sugar compound that has been successful in laboratory studies.
The girls were diagnosed in October 2007 with NP-C. There's currently no known cure for the disease, which also is referred to as childhood Alzheimer's.
It causes cholesterol to build up and get trapped inside the cells, which leads to debilitating neurological and physical problems.
The process eventually slows down cells and leads to cell death. Most patients with NP-C don't live past their teens, according to the National Niemann-Pick Disease Foundation.
The girls' parents, Hugh and Chris Hempel, said they're optimistic about the use of cyclodextrin - an additive in cholesterol-free foods that studies show also might help combat the HIV virus.
"I'm fairly confident, but the question is about the dosing. They're getting half the recommended dose," Hugh Hempel told the Reno Gazette-Journal.
"The FDA asked us to start slowly. So, there will be proving to the FDA that it's safe," he said.
Dr. Ron Browne of Sun Valley, Idaho has been a liaison between the FDA and some families with children living with NP-C. He said the Hempels got approved for cyclodextrin through the FDA "compassionate use" program. Their condition will be evaluated every few weeks.
"The FDA is usually cautious," Browne said. "There needs to be life-threatening situations where no other option is available."
The girls, who wear diapers, began losing their ability to speak several months ago, Chris Hempel said.
"They used to be able to sing nursery rhymes and say their names but they've regressed, like any neurological condition," Chris Hempel said. "We can understand what they want, and they're still taking in what we're saying."
Chris Hempel said staying positive is the only choice available.
"You have to be positive when you have kids in this situation," she said.
---
Information from: Reno Gazette-Journal, http://www.rgj.com
©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
Researchers identify compound that frees trapped cholesterol
Jan 26, 2009 |
not rated yet |
0
-
FDA approves skin cancer drug
Oct 13, 2006 |
not rated yet |
0
-
FDA approves antiretroviral drug
Aug 07, 2007 |
not rated yet |
0
-
FDA reviews diabetic and HIV medications
Mar 27, 2008 |
not rated yet |
0
-
FDA approves drug for autism irritability
Oct 13, 2006 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (4) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Starve a virus, feed a cure? Findings show how some cells protect themselves against HIV
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online ...
11 hours ago |
5 / 5 (2) |
0
|
Overeating may double risk of memory loss
New research suggests that consuming between 2,100 and 6,000 calories per day may double the risk of memory loss, or mild cognitive impairment (MCI), among people age 70 and older. The study was released today and will be ...
Medicine & Health / Neuroscience
8 hours ago |
5 / 5 (2) |
0
|
Declining health-care productivity in England: Who says so?
Reports that the National Health Service in England has been declining in productivity in the last decade appear to have been accepted as fact. However, a Viewpoint published Online First by The Lancet disputes this. The Vi ...
6 hours ago |
1 / 5 (1) |
0
Injured boomers beware: Know when to see doctor
(AP) -- It happened to nurse Jane Byron years after an in-line skating fall, business owner Haralee Weintraub while doing "men's" push-ups, and avid cyclist Gene Wilberg while lifting a heavy box.
13 hours ago |
5 / 5 (1) |
0
FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...
Medicine & Health / Neuroscience
Feb 09, 2012 |
4.9 / 5 (58) |
17
|
Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy
For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...
New method to examine batteries -- MRI from the inside
There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...
A mitosis mystery solved: How chromosomes align perfectly in a dividing cell
Although the process of mitotic cell division has been studied intensely for more than 50 years, Whitehead Institute researchers have only now solved the mystery of how cells correctly align their chromosomes during symmetric ...
Google might launch Drive for cloud storage soon
(PhysOrg.com) -- Google's next big move, according to the Wall Street Journal, is a cloud storage service called Drive. Hardly first to the plate, Google is simply catching up to introducing its cloud reposi ...
Lab study raises questions over nano-particle impact
Tests involving chickens have raised questions about the impact on health from engineered nano-particles, the ultra-fine grains commonly used in drugs and processed foods, scientists said on Sunday.
Researchers find extensive RNA editing in human transcriptome
In a new study published online in Nature Biotechnology, researchers from BGI, the world's largest genomics organization, reported the evidence of extensive RNA editing in a human cell line by analysis of RNA-seq data, demons ...